# Contact Order Wolverine: Editorial Inquiries on the BPC-157 TB-500 Digest

> Contact Order Wolverine with editorial questions or corrections about the BPC-157 TB-500 research and regulatory digest. Editorial inquiries only — not a clinic, not a vendor, not a prescriber.

Editorial questions, corrections, and sourcing notes about the BPC-157 TB-500 digest are welcome. This is an editorial desk, not a clinic and not a sales channel.

## Editorial inquiries only

Use the form to reach the editorial desk about the BPC-157 TB-500 digest. We read every message about a citation, a figure, a possible error, or a regulatory update we should reflect. If a study has been superseded, a DOI has moved, or the FDA record has changed, tell us and we will check it against the primary source.

What this desk is not: it is not a clinic, not a pharmacy, not a prescriber, and not a vendor. We cannot evaluate your health, recommend a dose, supply any peptide, or advise on obtaining the Wolverine blend. We do not provide medical or legal advice. Questions of that kind belong with an appropriately licensed professional, not with an editorial project.

## What to expect

We prioritize messages that improve the accuracy of the record: a miscited PMID, a number that does not match the source paper, a regulatory development we have not yet incorporated, or a place where the [Wolverine legal status and FDA 503A compounding access](/legal-status) page should be updated to reflect a new FDA action. Corrections grounded in a primary source are the fastest to act on.

We do not collect personal health information, and we ask that you not send any. Keep inquiries to the editorial content itself — the studies, the citations, the regulatory status, and the way the blend's evidence is set down on these pages. For the underlying sources, the [full reference list with PMIDs and DOIs](/references) lists everything cited, with DOIs and PubMed or FDA links, so a correction can be checked against the primary record before we change anything in the register.

---

The Wolverine blend kept as a kiln-fired formulary entry — BPC-157 and TB-500 set down as two annotated specimens, their measured animal-model findings inked and their unproven join left in the warm margin, with the FDA 503A and WADA record pinned to the page and nothing here prescribed or sold.